Search

Search Constraints

You searched for: Author/Creator Keating, Michael J

Search Results

3. Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study. Issue 10 (October 2016)

9. Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study. Issue 11 (November 2019)